AREV Life Sciences Global Corp.
AREVFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$15881
P/E Ratio—
52W High$0.01
52W Low$0.0005
AREV Life Sciences Global Corp. (AREVF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AREVF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $0.25M | $0.19M | $0.19M | $0.00M |
| Cost of Revenue | $0.02M | $0.07M | $0.00M | $0.07M | $0.05M |
| Gross Profit | $0.03M | $0.19M | $0.19M | $0.13M | ($0.05M) |
| Gross Margin %(computed) | 59.33% | 72.60% | 100.00% | 66.33% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.08M | $0.15M | $0.13M | $1.15M | $0.20M |
| G&A Expenses | $0.99M | $1.44M | $0.56M | $1.96M | $1.53M |
| Total Operating Expenses | $1.29M | $1.68M | $0.64M | $3.22M | $1.69M |
| Operating Income | ($1.39M) | ($1.50M) | ($0.45M) | ($3.03M) | ($1.69M) |
| Operating Margin %(computed) | — | -587.00% | -237.34% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.05M | $0.06M | $0.07M | $0.04M |
| Income Before Tax | ($1.44M) | ($0.99M) | ($1.05M) | ($3.19M) | ($8.43M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.04M |
| Net Income | ($1.44M) | ($0.99M) | ($1.05M) | ($3.19M) | ($8.43M) |
| Net Margin %(computed) | — | -388.36% | -550.37% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.05 | $-0.04 | $-0.07 | $-0.36 | $-1.47 |
| Wtd Avg Shares | 30.07M | 27.47M | 15.36M | 8.96M | 5.73M |
| EBITDA | ($1.31M) | ($0.80M) | ($0.50M) | ($3.05M) | ($1.64M) |
| EBITDA Margin %(computed) | — | -312.80% | -262.26% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more AREV Life Sciences Global Corp. data
About AREV Life Sciences Global Corp. (AREVF) Income Statement
AREV Life Sciences Global Corp. (AREVF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, AREVF reported revenue of $0.00B, gross profit of $0.00B (gross margin 59.33%), and net income of ($0.00B) — a net profit margin of -2940.37%.
Frequently asked questions
AREVF · 4 questionsAREV Life Sciences Global Corp. (AREVF) reported revenue of $0.00B for 2022, down 80.7% year-over-year.
AREVF revenueAREVF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09